Biofrontera Stock Investor Sentiment
| BFRI Stock | USD 0.90 0.01 1.46% |
Under 53% of Biofrontera's investor base is interested to short. The analysis of the overall investor sentiment regarding Biofrontera suggests that many traders are impartial. Biofrontera's investing sentiment shows overall attitude of investors towards Biofrontera.
Biofrontera | Build AI portfolio with Biofrontera Stock |
Biofrontera Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Biofrontera can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors may consider stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to consider selling stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of Biofrontera's Stock prices. Below is the latest headlines and news related to Biofrontera Stock. Current markets are strongly bearish. About 88% of major world exchanges and indexes are down. See today's market update for more information.
There is far too much social signal, news, headlines, and media speculation about Biofrontera that are available to investors today. This information is accessible both publicly - through Biofrontera's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Biofrontera-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Biofrontera news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Biofrontera relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Biofrontera's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Biofrontera alpha.
Biofrontera Largest EPS Surprises
Earnings surprises can significantly impact Biofrontera's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2023-03-08 | 2022-12-31 | -0.11 | -0.14 | -0.03 | 27 | ||
2022-04-08 | 2022-03-31 | -0.18 | -0.15 | 0.03 | 16 | ||
2021-12-31 | 2021-12-31 | -0.18 | -0.15 | 0.03 | 16 | ||
2023-05-12 | 2023-03-31 | -0.19 | -0.28 | -0.09 | 47 | ||
2025-03-13 | 2024-12-31 | -0.07 | -0.232 | -0.162 | 231 | ||
2022-11-14 | 2022-09-30 | -0.29 | -0.11 | 0.18 | 62 |
There is far too much social signal, news, headlines, and media speculation about Biofrontera that are available to investors today. This information is accessible both publicly - through Biofrontera's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Biofrontera-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Biofrontera news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Biofrontera relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Biofrontera's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Biofrontera alpha.
Biofrontera Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Biofrontera Stock Drop Looks Sharp, But How Deep Can It Go - Trefis | 12/05/2025 |
2 | Biofrontera Received Notice of Noncompliance - TradingView Track All Markets | 01/07/2026 |
3 | Theres No Escaping Biofrontera Inc.s Muted Revenues Despite A 42 percent Share Price Rise | 01/23/2026 |
4 | Earnings Miss Will Biofrontera Inc stock go up in YEAR - July 2025 Rallies Community Trade Idea Sharing Platform - baoquankhu1.vn | 01/29/2026 |
5 | Biofrontera Announces Positive Results in Phase 3 Study of Ameluz PDT for Actinic Keratoses on the Extremities, Neck, and Trunk, Meeting Primary Endpoint | 02/09/2026 |
6 | Biofrontera Inc. Announces Database Lock of Phase 1 Pharmacokinetics Study of Ameluz for Actinic Keratoses on Trunk and Extremities | 02/17/2026 |
7 | RenovaCare vs. Biofrontera Head-To-Head Review | 02/23/2026 |
Complementary Tools for Biofrontera Stock analysis
When running Biofrontera's price analysis, check to measure Biofrontera's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biofrontera is operating at the current time. Most of Biofrontera's value examination focuses on studying past and present price action to predict the probability of Biofrontera's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biofrontera's price. Additionally, you may evaluate how the addition of Biofrontera to your portfolios can decrease your overall portfolio volatility.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |